Metabolic and immunological features of the failing islet-transplanted patient

20Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

OBJECTIVE -This retrospective study was designed to identify metabolic and immune predictors of early islet allograft failure. RESEARCH DESIGN AND METHODS -We measured several metabolic and immunological markers at the time of pretransplant and several time points posttransplantation in 17 patients with long-term functioning graft (long fx) and 20 patients with short-term functioning graft (short fx). RESULTS -The short fx group showed higher insulin resistance, altered proinsulin processing, lower soluble interleukin-2 receptor (sIL-2r) (marker of T-cell activation), and higher soluble FasL (marker of apoptosis) during the entire follow-up, particularly at time of failure. CONCLUSIONS -Patients who experienced an early failure of islet allograft showed specific metabolic and immunological signs long before islet failure. © 2008 by the American Diabetes Association.

Cite

CITATION STYLE

APA

Fiorina, P., Vergani, A., Petrelli, A., D’Addio, F., Monti, L., Abdi, R., … Secchi, A. (2008). Metabolic and immunological features of the failing islet-transplanted patient. Diabetes Care, 31(3), 436–438. https://doi.org/10.2337/dc07-1831

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free